Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | GMNN | O75496 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11584970 | 0.94 | MAPK1 (0.58) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL11581295 | 0.94 | MAPK1 (0.58) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL1483375 | 0.94 | MAPK1 (0.58) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL11581266 | 0.94 | MAPK1 (0.58) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL11787560 | 0.93 | MAPK1 (0.57) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL1483876 | 0.91 | MAPK1 (0.54) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL1484416 | 0.90 | MAPK1 (0.51) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL15216421 | 0.89 | MAPK1 (0.53) | MAPK1MAPTLMNAALDH1A1MEN1 | |
| SCHEMBL15216484 | 0.89 | MAPK1 (0.53) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL15216416 | 0.89 | MAPK1 (0.53) | MAPK1MAPTLMNAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9598359-B2 | Sulfonates from natural oil metathesis | STEPAN COMPANY (US) | 2017-03-21 | — | — | US | disclosed |
| US-9598359-B2 | Sulfonates from natural oil metathesis | STEPAN COMPANY (US) | 2017-03-21 | — | — | US | disclosed |
| US-9303234-B2 | Hard surface cleaners based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-9303234-B2 | Hard surface cleaners based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130225469-A1 | HARD SURFACE CLEANERS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225469-A1 | HARD SURFACE CLEANERS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STS, SULT1E1, SULT1A1 | MAPK1 2093/4885MAPT 3317/4885LMNA 4164/4885 |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, AADAT, SQLE | MAPK1 3612/4885MAPT 2553/4885LMNA 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.